Trending stocks, Feb 13 2025

$VRT has released its Q4 2024 earnings, showing strong performance with an EPS of $0.99, beating estimates by $0.17, and a 25.79% year-over-year revenue increase to $2.35B 🌟. Key highlights include an adjusted operating profit of $504M and a 21.5% operating margin, indicating strong profitability. However, caution is warranted with EMEA showing weaker orders recently, contrasting with robust demand in the Americas 📊. The outlook for 2025 remains optimistic with projected EPS growth and strategic investments in tech. For further details, visit valueverge.com/VRT.

$HOOD has released its Q4 2024 earnings, reporting impressive results with EPS of $1.01 and revenue surpassing $1 billion for the first time as a public company, representing a 115.29% growth year-over-year. 📈

$TTD reports Q4 2024 earnings: EPS at $0.59 beats expectations, while revenue of $741M grows 22% but misses forecasts by $18.55M. The company highlighted execution missteps affecting performance, despite a strong year overall with $2.4B in revenue. Key risks include ongoing operational adjustments and increased competition in the digital ad space. Future opportunities lie in CTV growth and AI investments to enhance service delivery. Adjusted EBITDA for Q4 is $350M. 📈💼 Check details in valueverge.com/TTD.

$CVS has released new earnings for Q4 2024, showing an EPS of $1.19, surpassing estimates by $0.27, and revenue of $97.71B, up 4.15% Y/Y. Highlights include strong growth in healthcare benefits, but concerns remain about the Aetna business with a medical benefit ratio of 94.8%. Risks persist, including rising healthcare costs. Future opportunities aim for adjusted EPS of $5.75-$6.00 in 2025, supported by increased investment in integrated capabilities and technology. 🌟📈 Check details in valueverge.com/CVS.

$CME has released its Q4 2024 earnings results. Key highlights include an EPS of $2.52 (beating estimates) and revenues of $1.53B, up 6% year-over-year. CME's average daily volume increased by 9% to 26.9 million contracts, marking four consecutive years of record volume across all asset classes. 📈 However, risks include ongoing geopolitical tensions and persistent inflation.

$EQIX provides insights after its latest earnings release. Q4 revenue reached $2.26B, a 7% increase Y/Y, slightly missing estimates. EPS came in at $3.13, beating projections by $0.39. Key highlights include a 10% rise in AFFO and continued focus on AI workloads. Risks involve pressure from a stronger dollar and capacity constraints in Tier 1 metros. Future opportunities hinge on their robust backlog and expanding data centers. For more details, check out valueverge.com/EQIX. 📈💡

$APP has released its Q4 2024 earnings, showing significant growth with an EPS of $1.73, beating estimates by $0.47. Revenue reached $1.37B, a 44% year-over-year increase, highlighting strong performance in the Advertising sector, which generated $999M in revenue. 🚀💰 Risks include increased operational costs and challenges in scaling their ecommerce efforts, but the future potential remains promising as demand from advertisers grows. For more details, check valueverge.com/APP.

$CSCO has released its Q2 2025 earnings, showing strong performance with an EPS of $0.94, beating expectations, and revenue of $13.99B, marking a 9.38% YoY growth. 📈 Key highlights include double-digit growth in annualized recurring revenue and subscription revenue representing 56% of total revenue. However, risks remain with increasing tariffs affecting costs. Future opportunities lie in AI infrastructure development, with AI orders surpassing $700 million. ⚠️ Check details at valueverge.com/CSCO.

Trending stocks, Feb 12 2025